Signal-Regulated Kinase Activation Mobilization and Extracellular Platelet-Activating Factor-Mediated Calcium Caveolae Facilitate but Are Not Essential for

Certain proteins, including receptors and signaling molecules, are known to be enriched in caveolae and lipid rafts. Caveolin-1, the major structural protein of caveolae, specifically interacts with many signaling molecules and, thus, caveolae and lipid rafts are often seen as preassembled signaling platforms. A potential binding site for caveolin-1 is present in the platelet-activating factor receptor (PAFR) sequence, and many downstream signaling components of PAFR activation preferentially localize in caveolae. The aim of this study was to investigate whether the PAFR was localized in caveolae/lipid raft domains and, if so, what would be the significance of such localization for PAFR signaling. In this study, we demonstrate that PAFR localizes within membrane microdomains, in close proximity to caveolin-1 in living cells, with potential interaction through a caveolin-1-binding sequence in the PAFR C terminus. Caveolin-1, however, is not essential for PAFR localization in lipid rafts. Disruption of caveolae/lipid rafts with methyl- (cid:1) -cyclodextrin markedly reduced PAF-triggered inositol phosphate production and cytosolic calcium flux, suggesting that PAFR signaling through the G (cid:2) q protein was critically dependent on integrity of lipid rafts and/or caveolae. Interestingly, whereas in caveolin-1-expressing cells lipid raft disruption markedly decreased PAFR-mediated activation of the ERK/MAPK pathway, in cells lacking caveolae, such as leukocytes, lipid raft disruption had either the same inhibitory effect (Ramos B cells) or no effect (monocytes) on PAFR capacity to signal through the ERK/MAPK pathway. In conclusion, PAFR

[1]  J. Novotný,et al.  Agonist-induced tyrosine phosphorylation of Gq/G11 alpha requires the intact structure of membrane domains. , 2005, Biochemical and biophysical research communications.

[2]  B. Roth,et al.  Caveolin-1 Interacts with 5-HT2A Serotonin Receptors and Profoundly Modulates the Signaling of Selected Gαq-coupled Protein Receptors* , 2004, Journal of Biological Chemistry.

[3]  A. Heding.  Use of the BRET 7TM receptor/β-arrestin assay in drug discovery and screening , 2004 .

[4]  R. Tikkanen,et al.  Membrane and raft association of reggie-1/flotillin-2: role of myristoylation, palmitoylation and oligomerization and induction of filopodia by overexpression. , 2004, The Biochemical journal.

[5]  M. Lussier,et al.  Exocytotic Insertion of TRPC6 Channel into the Plasma Membrane upon Gq Protein-coupled Receptor Activation* , 2004, Journal of Biological Chemistry.

[6]  S. Schulz,et al.  Heterodimerization of Substance P and μ-Opioid Receptors Regulates Receptor Trafficking and Resensitization* , 2003, Journal of Biological Chemistry.

[7]  J. Stankova,et al.  Trafficking, Ubiquitination, and Down-regulation of the Human Platelet-activating Factor Receptor* , 2003, Journal of Biological Chemistry.

[8]  J. Stankova,et al.  Activation of ERK1/2 by platelet-activating factor receptor is independent of receptor internalisation and G-protein activation. , 2003, Cellular signalling.

[9]  A. Nel,et al.  The flotillins are integral membrane proteins in lipid rafts that contain TCR-associated signaling components: implications for T-cell activation. , 2003, Clinical immunology.

[10]  D. Gingras,et al.  Agonist-independent Desensitization and Internalization of the Human Platelet-activating Factor Receptor by Coumermycin-Gyrase B-induced Dimerization* , 2003, Journal of Biological Chemistry.

[11]  H. Plattner,et al.  Asymmetric localization of flotillins/reggies in preassembled platforms confers inherent polarity to hematopoietic cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[12]  S. Chakrabarty,et al.  Platelet-activating factor activates mitogen-activated protein kinases, inhibits proliferation, induces differentiation and suppresses the malignant phenotype of human colon carcinoma cells , 2003, Oncogene.

[13]  L. Pike.  Lipid rafts Published, JLR Papers in Press, February 1, 2003. DOI 10.1194/jlr.R200021-JLR200 , 2003, Journal of Lipid Research.

[14]  T. Kohout,et al.  Homo- and Hetero-oligomerization of Thyrotropin-releasing Hormone (TRH) Receptor Subtypes , 2002, The Journal of Biological Chemistry.

[15]  D. James,et al.  Flotillin-1/Reggie-2 Traffics to Surface Raft Domains via a Novel Golgi-independent Pathway , 2002, The Journal of Biological Chemistry.

[16]  R. Leduc,et al.  A polyaromatic caveolin-binding-like motif in the cytoplasmic tail of the type 1 receptor for angiotensin II plays an important role in receptor trafficking and signaling. , 2002, Endocrinology.

[17]  S. Choufani,et al.  Proinflammatory Gene Induction by Platelet-Activating Factor Mediated Via Its Cognate Nuclear Receptor1 , 2002, The Journal of Immunology.

[18]  Takao Shimizu,et al.  Platelet-activating factor receptor. , 2002, Prostaglandins & other lipid mediators.

[19]  E. Bulger,et al.  Platelet-activating factor priming of inflammatory cell activity requires cellular adherence. , 2002, Surgery.

[20]  J. Stankova,et al.  Agonist-induced Internalization of the Platelet-activating Factor Receptor Is Dependent on Arrestins but Independent of G-protein Activation , 2002, The Journal of Biological Chemistry.

[21]  J. Travers,et al.  The platelet-activating factor receptor activates the extracellular signal-regulated kinase mitogen-activated protein kinase and induces proliferation of epidermal cells through an epidermal growth factor-receptor-dependent pathway. , 2002, Journal of Pharmacology and Experimental Therapeutics.

[22]  J. Stankova,et al.  Inverse agonist activity of selected ligands of platelet-activating factor receptor. , 2001, The Journal of pharmacology and experimental therapeutics.

[23]  Michael P. Lisanti,et al.  Emerging Themes in Lipid Rafts and Caveolae , 2001, Cell.

[24]  J. Stankova,et al.  G-protein-independent Activation of Tyk2 by the Platelet-activating Factor Receptor* , 2001, The Journal of Biological Chemistry.

[25]  P. Oh,et al.  Segregation of heterotrimeric G proteins in cell surface microdomains. G(q) binds caveolin to concentrate in caveolae, whereas G(i) and G(s) target lipid rafts by default. , 2001, Molecular biology of the cell.

[26]  P. Schnetkamp,et al.  Transient Translocation of the B Cell Receptor and Src Homology 2 Domain-Containing Inositol Phosphatase to Lipid Rafts: Evidence Toward a Role in Calcium Regulation1 , 2000, The Journal of Immunology.

[27]  M. Lisanti,et al.  A Molecular Dissection of Caveolin-1 Membrane Attachment and Oligomerization , 2000, The Journal of Biological Chemistry.

[28]  S. Angers,et al.  Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET). , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[29]  T. Horie,et al.  PAF-induced RANTES production by human airway smooth muscle cells requires both p38 MAP kinase and Erk. , 2000, American journal of respiratory and critical care medicine.

[30]  Deborah A. Brown,et al.  Lipid-dependent Targeting of G Proteins into Rafts* , 2000, The Journal of Biological Chemistry.

[31]  I. Iwamoto,et al.  Platelet‐activating factor activates mitogen‐activated protein kinases through the activation of phosphatidylinositol 3‐kinase and tyrosine kinase in human eosinophils , 2000, Journal of leukocyte biology.

[32]  J. Engelman,et al.  Caveolins, Liquid-Ordered Domains, and Signal Transduction , 1999, Molecular and Cellular Biology.

[33]  J. Engelman,et al.  Caveolin‐mediated regulation of signaling along the p42/44 MAP kinase cascade in vivo , 1998, FEBS letters.

[34]  M. Lisanti,et al.  Caveolins, a Family of Scaffolding Proteins for Organizing “Preassembled Signaling Complexes” at the Plasma Membrane* , 1998, The Journal of Biological Chemistry.

[35]  J. Kawabe,et al.  Caveolin Interaction with Protein Kinase C , 1997, The Journal of Biological Chemistry.

[36]  J. Stankova,et al.  Structural and Functional Requirements for Agonist-induced Internalization of the Human Platelet-activating Factor Receptor* , 1997, The Journal of Biological Chemistry.

[37]  H. Bazan,et al.  A mitogen-activated protein kinase (MAP-kinase) cascade is stimulated by platelet activating factor (PAF) in corneal epithelium. , 1997, Current eye research.

[38]  Tsuneya Ikezu,et al.  Identification of Peptide and Protein Ligands for the Caveolin-scaffolding Domain , 1997, The Journal of Biological Chemistry.

[39]  J. Stankova,et al.  Modulation of human platelet-activating factor receptor gene expression by protein kinase C activation. , 1996, Journal of immunology.

[40]  J. Stankova,et al.  Identification of Transmembrane Domain Residues Determinant in the Structure-Function Relationship of the Human Platelet-activating Factor Receptor by Site-directed Mutagenesis* , 1996, The Journal of Biological Chemistry.

[41]  R. Fisher,et al.  The Third Intracellular Domain of the Platelet-activating Factor Receptor Is a Critical Determinant in Receptor Coupling to Phosphoinositide Phospholipase C-activating G Proteins , 1996, The Journal of Biological Chemistry.

[42]  R. Hurst,et al.  trp, a Novel Mammalian Gene Family Essential for Agonist-Activated Capacitative Ca2+ Entry , 1996, Cell.

[43]  M. Lisanti,et al.  Co-purification and Direct Interaction of Ras with Caveolin, an Integral Membrane Protein of Caveolae Microdomains , 1996, The Journal of Biological Chemistry.

[44]  Takao Shimizu,et al.  Platelet-activating factor receptor: gene expression and signal transduction. , 1995, Biochimica et biophysica acta.

[45]  C. Mineo,et al.  A detergent-free method for purifying caveolae membrane from tissue culture cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[46]  Takao Shimizu,et al.  Platelet-activating factor receptor. , 1995, Journal of biochemistry.

[47]  M. Lisanti,et al.  Oligomeric structure of caveolin: implications for caveolae membrane organization. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[48]  F. Vogel,et al.  VIP21-caveolin, a membrane protein constituent of the caveolar coat, oligomerizes in vivo and in vitro. , 1995, Molecular biology of the cell.

[49]  M. Lisanti,et al.  Evidence for a Regulated Interaction between Heterotrimeric G Proteins and Caveolin , 1995, The Journal of Biological Chemistry.

[50]  A. Tordai,et al.  Platelet activating factor activates MAPK and increases in intracellular calcium via independent pathways in B lymphocytes. , 1995, Biochemical and biophysical research communications.

[51]  E. Nishida,et al.  Transfected platelet-activating factor receptor activates mitogen-activated protein (MAP) kinase and MAP kinase kinase in Chinese hamster ovary cells. , 1994, The Journal of biological chemistry.

[52]  M. Lisanti,et al.  Caveolin forms a hetero-oligomeric protein complex that interacts with an apical GPI-linked protein: implications for the biogenesis of caveolae , 1993, The Journal of cell biology.

[53]  M. Simon,et al.  Specific interactions of chemoattractant factor receptors with G-proteins. , 1993, The Journal of biological chemistry.

[54]  Takao Shimizu,et al.  Cloning by functional expression of platelet-activating factor receptor from guinea-pig lung , 1991, Nature.

[55]  P. Barnes,et al.  [3H]WEB 2086 labels platelet activating factor receptors in guinea pig and human lung. , 1989, European journal of pharmacology.

[56]  P. Barnes,et al.  Radioligand binding of antagonists of platelet‐activating factor to intact human platelets , 1988, FEBS letters.

[57]  R. Tsien,et al.  A new generation of Ca2+ indicators with greatly improved fluorescence properties. , 1985, The Journal of biological chemistry.

[58]  P. Henson,et al.  LEUKOCYTE-DEPENDENT HISTAMINE RELEASE FROM RABBIT PLATELETS , 1972, The Journal of experimental medicine.

[59]  Ching-Mei Hsu,et al.  Different pathways leading to activation of extracellular signal-regulated kinase and p38 MAP kinase by formyl-methionyl-leucyl-phenylalanine or platelet activating factor in human neutrophils. , 2005, Journal of biomedical science.

[60]  U. Pendurthi,et al.  Acute cholesterol depletion impairs functional expression of tissue factor in fibroblasts: modulation of tissue factor activity by membrane cholesterol. , 2005, Blood.

[61]  C. D. de Koster,et al.  Comparative proteomics of human endothelial cell caveolae and rafts using two‐dimensional gel electrophoresis and mass spectrometry , 2004, Electrophoresis.

[62]  M. Resh.  Membrane targeting of lipid modified signal transduction proteins. , 2004, Sub-cellular biochemistry.

[63]  J. Novotný,et al.  Biochemistry of transmembrane signaling mediated by trimeric G proteins. , 2004, Physiological research.

[64]  K. Eidne,et al.  New Technologies: Bioluminescence Resonance Energy Transfer (BRET) for the Detection of Real Time Interactions Involving G-Protein Coupled Receptors , 2004, Pituitary.

[65]  W. Krajewska,et al.  Caveolins: structure and function in signal transduction. , 2004, Cellular & molecular biology letters.

[66]  M. Bastmeyer,et al.  The lipid raft microdomain-associated protein reggie-1/flotillin-2 is expressed in human B cells and localized at the plasma membrane and centrosome in PBMCs. , 2002, Immunobiology.

[67]  G. Zimmerman,et al.  Platelet-activating factor and related lipid mediators. , 2000, Annual review of biochemistry.

[68]  Simon P. Anderson,et al.  Advertising Content , 2004 .